Levofloxacin Infusion IP 0.5% w/v – Quilox Infusion

Levofloxacin Infusion IP 0.5% w/v – Potent IV Antibiotic for Systemic Infections.

Quilox Infusion: The composition of Levofloxacin 500mg/100ml is a broad-spectrum fluoroquinolone that inhibits bacterial DNA gyrase and topoisomerase IV. It delivers rapid, bactericidal activity and is particularly effective for respiratory, urinary, and intra-abdominal infections. Its once-daily dosing and tissue penetration profile ensure clinical effectiveness in both moderate and severe cases.

Recommended By Specialists:
Infectious Disease Specialists -It is preferred to treat the disease associated with broad-spectrum bacterial infections.
General Physicians: It is preferred to treat systemic bacterial infections.
Pulmonologists: It is preferred to treat the disease associated with infections (pneumonia, bronchitis, TB-related infections).

Key Benefits of Levofloxacin Infusion IP 0.5% w/v – Quilox Infusion:
Rapid Onset with High Bioavailability – It provides systemic antibacterial action through the intravenous route and is especially useful in severe infections and hospitalised patients.
Broad-Spectrum Coverage – Active against a wide range of aerobic gram-positive and gram-negative bacteria, including atypical respiratory pathogens.
Seamless Oral-to-IV Transition – Ideal for step-up and step-down therapy, as IV and oral formulations are bioequivalent, simplifying inpatient to outpatient conversion.

INDICATIONS:
Hospital-Acquired & Community-Acquired Pneumonia
Complicated Urinary Tract Infections
Pyelonephritis
Skin & Soft Tissue Infections
Intra-abdominal Infection